Cargando…

Pasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation

BACKGROUND: Pasteurella multocida toxin (PMT) is a potent inducer of osteoclast formation. Pigs suffering from an infection with toxigenic Pasteurella multocida strains develop atrophic rhinitis characterised by a loss of turbinate bones and conchae. However, on the molecular level the process of bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kloos, Bianca, Chakraborty, Sushmita, Lindner, Sonja G., Noack, Katrin, Harre, Ulrike, Schett, Georg, Krämer, Oliver H., Kubatzky, Katharina F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570759/
https://www.ncbi.nlm.nih.gov/pubmed/26369790
http://dx.doi.org/10.1186/s12964-015-0117-7
_version_ 1782390258042667008
author Kloos, Bianca
Chakraborty, Sushmita
Lindner, Sonja G.
Noack, Katrin
Harre, Ulrike
Schett, Georg
Krämer, Oliver H.
Kubatzky, Katharina F.
author_facet Kloos, Bianca
Chakraborty, Sushmita
Lindner, Sonja G.
Noack, Katrin
Harre, Ulrike
Schett, Georg
Krämer, Oliver H.
Kubatzky, Katharina F.
author_sort Kloos, Bianca
collection PubMed
description BACKGROUND: Pasteurella multocida toxin (PMT) is a potent inducer of osteoclast formation. Pigs suffering from an infection with toxigenic Pasteurella multocida strains develop atrophic rhinitis characterised by a loss of turbinate bones and conchae. However, on the molecular level the process of bone loss remains largely uncharacterised. RESULTS: Recently it was found that PMT activates the serine/threonine kinase mammalian target of rapamycin (mTOR) in fibroblasts. Using RAW264.7 macrophages, we investigated the role of the mTOR complex 1 (mTORC1) in PMT-mediated osteoclast formation. PMT induces the differentiation of RAW264.7 macrophages into multinucleated, tartrate resistant acid phosphatase (TRAP) positive osteoclasts that are capable to resorb bone. In the presence of the mTORC1 inhibitor rapamycin, PMT was significantly less able to induce the formation of TRAP-positive osteoclasts. Accordingly, the resulting resorption of bone was strongly reduced. A major target of mTOR is the 70 kDa ribosomal protein S6 kinase 1 (p70 S6K1). Activated p70 S6K1 decreases the expression of programmed cell death protein 4 (PDCD4), a negative transcriptional regulator of osteoclastogenesis, at the protein and gene level. Ultimately this results in the activation of c-Jun, a component of the activator protein 1 (AP-1) complex, which is a major transcription factor for the induction of osteoclast-specific genes. We now demonstrate that c-Jun and its downstream target, the osteoclast-specific bone degrading protease cathepsin K, are upregulated upon PMT treatment in an mTOR-dependent manner. CONCLUSIONS: Activation of mTOR signalling plays a central role in the formation of osteoclasts through the bacterial toxin PMT. On the molecular level, PMT-induced activation of mTOR leads to down regulation of PDCD4, a known repressor of AP-1 complex, culminating in the activation of c-Jun, an essential transcription factor for triggering osteoclastogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12964-015-0117-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4570759
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45707592015-09-16 Pasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation Kloos, Bianca Chakraborty, Sushmita Lindner, Sonja G. Noack, Katrin Harre, Ulrike Schett, Georg Krämer, Oliver H. Kubatzky, Katharina F. Cell Commun Signal Research BACKGROUND: Pasteurella multocida toxin (PMT) is a potent inducer of osteoclast formation. Pigs suffering from an infection with toxigenic Pasteurella multocida strains develop atrophic rhinitis characterised by a loss of turbinate bones and conchae. However, on the molecular level the process of bone loss remains largely uncharacterised. RESULTS: Recently it was found that PMT activates the serine/threonine kinase mammalian target of rapamycin (mTOR) in fibroblasts. Using RAW264.7 macrophages, we investigated the role of the mTOR complex 1 (mTORC1) in PMT-mediated osteoclast formation. PMT induces the differentiation of RAW264.7 macrophages into multinucleated, tartrate resistant acid phosphatase (TRAP) positive osteoclasts that are capable to resorb bone. In the presence of the mTORC1 inhibitor rapamycin, PMT was significantly less able to induce the formation of TRAP-positive osteoclasts. Accordingly, the resulting resorption of bone was strongly reduced. A major target of mTOR is the 70 kDa ribosomal protein S6 kinase 1 (p70 S6K1). Activated p70 S6K1 decreases the expression of programmed cell death protein 4 (PDCD4), a negative transcriptional regulator of osteoclastogenesis, at the protein and gene level. Ultimately this results in the activation of c-Jun, a component of the activator protein 1 (AP-1) complex, which is a major transcription factor for the induction of osteoclast-specific genes. We now demonstrate that c-Jun and its downstream target, the osteoclast-specific bone degrading protease cathepsin K, are upregulated upon PMT treatment in an mTOR-dependent manner. CONCLUSIONS: Activation of mTOR signalling plays a central role in the formation of osteoclasts through the bacterial toxin PMT. On the molecular level, PMT-induced activation of mTOR leads to down regulation of PDCD4, a known repressor of AP-1 complex, culminating in the activation of c-Jun, an essential transcription factor for triggering osteoclastogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12964-015-0117-7) contains supplementary material, which is available to authorized users. BioMed Central 2015-09-14 /pmc/articles/PMC4570759/ /pubmed/26369790 http://dx.doi.org/10.1186/s12964-015-0117-7 Text en © Kloos et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kloos, Bianca
Chakraborty, Sushmita
Lindner, Sonja G.
Noack, Katrin
Harre, Ulrike
Schett, Georg
Krämer, Oliver H.
Kubatzky, Katharina F.
Pasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation
title Pasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation
title_full Pasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation
title_fullStr Pasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation
title_full_unstemmed Pasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation
title_short Pasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation
title_sort pasteurella multocida toxin- induced osteoclastogenesis requires mtor activation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570759/
https://www.ncbi.nlm.nih.gov/pubmed/26369790
http://dx.doi.org/10.1186/s12964-015-0117-7
work_keys_str_mv AT kloosbianca pasteurellamultocidatoxininducedosteoclastogenesisrequiresmtoractivation
AT chakrabortysushmita pasteurellamultocidatoxininducedosteoclastogenesisrequiresmtoractivation
AT lindnersonjag pasteurellamultocidatoxininducedosteoclastogenesisrequiresmtoractivation
AT noackkatrin pasteurellamultocidatoxininducedosteoclastogenesisrequiresmtoractivation
AT harreulrike pasteurellamultocidatoxininducedosteoclastogenesisrequiresmtoractivation
AT schettgeorg pasteurellamultocidatoxininducedosteoclastogenesisrequiresmtoractivation
AT krameroliverh pasteurellamultocidatoxininducedosteoclastogenesisrequiresmtoractivation
AT kubatzkykatharinaf pasteurellamultocidatoxininducedosteoclastogenesisrequiresmtoractivation